| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L EGF TBC1D3D MYCBP2 CDC42EP2 FGD1 RPGR TBC1D3I ARHGEF25 TBC1D3G GDPGP1 TBC1D3C TBC1D3B SYDE1 TBC1D3K TBC1D3F | 5.46e-16 | 507 | 62 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L EGF TBC1D3D MYCBP2 CDC42EP2 FGD1 RPGR TBC1D3I ARHGEF25 TBC1D3G GDPGP1 TBC1D3C TBC1D3B SYDE1 TBC1D3K TBC1D3F | 5.46e-16 | 507 | 62 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D CDC42EP2 TBC1D3I TBC1D3G TBC1D3C TBC1D3B SYDE1 TBC1D3K TBC1D3F | 2.64e-12 | 279 | 62 | 13 | GO:0005096 |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L EGF TBC1D3D MYCBP2 CDC42EP2 FGD1 RPGR TBC1D3I ARHGEF25 TBC1D3G GDPGP1 TBC1D3C TBC1D3B SYDE1 SLX4 TBC1D3K TBC1D3F SPINK5 | 7.15e-10 | 1418 | 62 | 21 | GO:0030234 |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L EGF TBC1D3D CDC42EP2 TBC1D3I TBC1D3G TBC1D3C TBC1D3B SYDE1 SLX4 TBC1D3K TBC1D3F | 1.06e-09 | 656 | 62 | 15 | GO:0008047 |
| GeneOntologyMolecularFunction | molecular function activator activity | TBC1D3E TBC1D3 CRLF1 TBC1D3H TBC1D3L EGF TBC1D3D CDC42EP2 TBC1D3I F2 TBC1D3G TBC1D3C TBC1D3B SYDE1 SLX4 TBC1D3K TBC1D3F | 1.29e-07 | 1233 | 62 | 17 | GO:0140677 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 8.04e-05 | 231 | 62 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.92e-03 | 21 | 62 | 2 | GO:0042975 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B SYDE1 TBC1D3K TBC1D3F | 3.57e-16 | 109 | 61 | 12 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B SYDE1 TBC1D3K TBC1D3F | 5.98e-12 | 244 | 61 | 12 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D FGD1 TBC1D3I TBC1D3G TBC1D3C TBC1D3B SYDE1 TBC1D3K TBC1D3F | 1.41e-11 | 335 | 61 | 13 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G BBC3 TBC1D3C TBC1D3B SYDE1 TBC1D3K TBC1D3F NLRP6 | 1.56e-10 | 499 | 61 | 14 | GO:0051345 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L EGF TBC1D3D NEURL1 ASXL2 TBC1D3I F2 TBC1D3G BBC3 TBC1D3C TBC1D3B SYDE1 TBC1D3K TBC1D3F NLRP6 | 5.33e-10 | 1028 | 61 | 18 | GO:0043085 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D FGD1 TBC1D3I TBC1D3G BBC3 TBC1D3C TBC1D3B SYDE1 TBC1D3K TBC1D3F SPINK5 NLRP6 | 3.41e-09 | 878 | 61 | 16 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | TBC1D3E TBC1D3 TBC1D3H TBC1D3L EGF TBC1D3D NEURL1 ASXL2 TBC1D3I F2 TBC1D3G BBC3 TBC1D3C TBC1D3B SYDE1 TBC1D3K TBC1D3F NLRP6 | 9.17e-08 | 1430 | 61 | 18 | GO:0044093 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 8.60e-06 | 44 | 61 | 4 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 1.33e-05 | 49 | 61 | 4 | GO:0050685 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 3.62e-05 | 63 | 61 | 4 | GO:0033120 | |
| GeneOntologyCellularComponent | PR-DUB complex | 5.01e-05 | 4 | 61 | 2 | GO:0035517 | |
| GeneOntologyCellularComponent | PcG protein complex | 4.72e-04 | 52 | 61 | 3 | GO:0031519 | |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.31e-16 | 49 | 59 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 7.79e-16 | 53 | 59 | 10 | PF00566 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.16e-15 | 55 | 59 | 10 | PS50086 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.16e-15 | 55 | 59 | 10 | IPR000195 |
| Domain | RBM1CTR | 1.66e-06 | 8 | 59 | 3 | PF08081 | |
| Domain | RBM1CTR | 1.66e-06 | 8 | 59 | 3 | IPR012604 | |
| Domain | HARE-HTH | 2.94e-05 | 3 | 59 | 2 | PF05066 | |
| Domain | ASXH | 2.94e-05 | 3 | 59 | 2 | PF13919 | |
| Domain | PHD_3 | 2.94e-05 | 3 | 59 | 2 | PF13922 | |
| Domain | ASX-like_PHD | 2.94e-05 | 3 | 59 | 2 | IPR026905 | |
| Domain | ASX/ASX-like | 2.94e-05 | 3 | 59 | 2 | IPR024811 | |
| Domain | ASXH | 2.94e-05 | 3 | 59 | 2 | IPR028020 | |
| Domain | HB1/Asxl_HTH | 2.94e-05 | 3 | 59 | 2 | IPR007759 | |
| Domain | RCC1 | 1.80e-03 | 20 | 59 | 2 | PF00415 | |
| Domain | RCC1_1 | 1.98e-03 | 21 | 59 | 2 | PS00625 | |
| Domain | RCC1_2 | 1.98e-03 | 21 | 59 | 2 | PS00626 | |
| Domain | RCC1_3 | 1.98e-03 | 21 | 59 | 2 | PS50012 | |
| Domain | Reg_chr_condens | 2.18e-03 | 22 | 59 | 2 | IPR000408 | |
| Domain | - | 2.18e-03 | 22 | 59 | 2 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 2.38e-03 | 23 | 59 | 2 | IPR009091 | |
| Domain | TRYPSIN_SER | 2.89e-03 | 90 | 59 | 3 | IPR033116 | |
| Domain | ZF_PHD_2 | 3.37e-03 | 95 | 59 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 3.47e-03 | 96 | 59 | 3 | PS01359 | |
| Domain | TRYPSIN_HIS | 4.23e-03 | 103 | 59 | 3 | IPR018114 | |
| Domain | TRYPSIN_SER | 4.59e-03 | 106 | 59 | 3 | PS00135 | |
| Domain | TRYPSIN_HIS | 4.71e-03 | 107 | 59 | 3 | PS00134 | |
| Domain | Peptidase_S1A | 5.48e-03 | 113 | 59 | 3 | IPR001314 | |
| Domain | TRYPSIN_DOM | 5.75e-03 | 115 | 59 | 3 | PS50240 | |
| Domain | Tryp_SPc | 6.04e-03 | 117 | 59 | 3 | SM00020 | |
| Domain | Trypsin | 6.62e-03 | 121 | 59 | 3 | PF00089 | |
| Domain | Trypsin_dom | 6.62e-03 | 121 | 59 | 3 | IPR001254 | |
| Domain | Peptidase_S1_PA | 6.93e-03 | 123 | 59 | 3 | IPR009003 | |
| Domain | Nucleotide-bd_a/b_plait | 8.94e-03 | 258 | 59 | 4 | IPR012677 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K | 2.55e-11 | 99 | 46 | 9 | M46448 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.26e-31 | 11 | 62 | 11 | 16863688 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 6.61e-11 | 74 | 62 | 7 | 16625196 | |
| Pubmed | 3.19e-10 | 7 | 62 | 4 | 8269511 | ||
| Pubmed | 4.48e-09 | 12 | 62 | 4 | 9598316 | ||
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 2.16e-08 | 4 | 62 | 3 | 12359748 | |
| Pubmed | 2.16e-08 | 4 | 62 | 3 | 8406013 | ||
| Pubmed | 5.38e-08 | 5 | 62 | 3 | 12604796 | ||
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 5.38e-08 | 5 | 62 | 3 | 8817321 | |
| Pubmed | 5.38e-08 | 5 | 62 | 3 | 8471161 | ||
| Pubmed | 5.38e-08 | 5 | 62 | 3 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 5.38e-08 | 5 | 62 | 3 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 5.38e-08 | 5 | 62 | 3 | 19737860 | |
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 18239052 | ||
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 1.07e-07 | 6 | 62 | 3 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 1.07e-07 | 6 | 62 | 3 | 12356914 | |
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 9499427 | ||
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 15184870 | ||
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 15051956 | ||
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 1.88e-07 | 7 | 62 | 3 | 8875892 | |
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 17001072 | ||
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 1.88e-07 | 7 | 62 | 3 | 10377282 | |
| Pubmed | 3.00e-07 | 8 | 62 | 3 | 7479793 | ||
| Pubmed | 6.42e-07 | 10 | 62 | 3 | 10601091 | ||
| Pubmed | 6.42e-07 | 10 | 62 | 3 | 9384609 | ||
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 1.17e-06 | 12 | 62 | 3 | 20543856 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 1.52e-06 | 13 | 62 | 3 | 23816659 | |
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 1.94e-06 | 14 | 62 | 3 | 14611631 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 2.42e-06 | 15 | 62 | 3 | 14762062 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 36068610 | ||
| Pubmed | ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia. | 3.13e-06 | 2 | 62 | 2 | 28516957 | |
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 3.60e-06 | 17 | 62 | 3 | 28115466 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 4.32e-06 | 18 | 62 | 3 | 12023983 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 21047783 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 16412590 | ||
| Pubmed | Diversity of human copy number variation and multicopy genes. | 9.37e-06 | 3 | 62 | 2 | 21030649 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 21212517 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 25835095 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 28063196 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 29284740 | ||
| Pubmed | Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase. | 9.37e-06 | 3 | 62 | 2 | 33731362 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 33751773 | ||
| Pubmed | 1.36e-05 | 26 | 62 | 3 | 35920200 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 34170818 | ||
| Pubmed | Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding. | 1.87e-05 | 4 | 62 | 2 | 34536441 | |
| Pubmed | Epidermal growth factor regulates hematopoietic regeneration after radiation injury. | 6.53e-05 | 7 | 62 | 2 | 23377280 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 11796824 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 26416890 | ||
| Pubmed | Additional sex combs-like family genes are required for normal cardiovascular development. | 1.12e-04 | 9 | 62 | 2 | 24860998 | |
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 1.32e-04 | 55 | 62 | 3 | 19468303 | |
| Pubmed | ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer. | 1.39e-04 | 10 | 62 | 2 | 32669118 | |
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 38671004 | ||
| Pubmed | The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. | 1.39e-04 | 10 | 62 | 2 | 19815555 | |
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 10332027 | ||
| Pubmed | 1.63e-04 | 59 | 62 | 3 | 11279525 | ||
| Pubmed | WT1 targets Gas1 to maintain nephron progenitor cells by modulating FGF signals. | 2.04e-04 | 12 | 62 | 2 | 25804736 | |
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 10749975 | ||
| Pubmed | Loss of the tumor suppressor BAP1 causes myeloid transformation. | 2.41e-04 | 13 | 62 | 2 | 22878500 | |
| Pubmed | 3.69e-04 | 16 | 62 | 2 | 20805357 | ||
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 5.82e-04 | 20 | 62 | 2 | 29785026 | |
| Pubmed | 6.64e-04 | 95 | 62 | 3 | 24029230 | ||
| Pubmed | 7.72e-04 | 23 | 62 | 2 | 20301575 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 1.27e-03 | 925 | 62 | 7 | 28986522 | |
| Pubmed | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. | 1.50e-03 | 32 | 62 | 2 | 23535730 | |
| Pubmed | 1.76e-03 | 486 | 62 | 5 | 20936779 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.27e-16 | 149 | 62 | 11 | chr17q12 |
| Cytoband | 17q12 | 2.47e-07 | 99 | 62 | 5 | 17q12 | |
| Cytoband | Yq11.223 | 2.79e-04 | 93 | 62 | 3 | Yq11.223 | |
| GeneFamily | RNA binding motif containing | 5.86e-04 | 213 | 33 | 4 | 725 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D ZSWIM5 ARHGEF25 TBC1D3G BBC3 TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.63e-13 | 213 | 59 | 12 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D ZSWIM5 ARHGEF25 TBC1D3G BBC3 TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.63e-13 | 213 | 59 | 12 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.09e-12 | 90 | 59 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L EGF TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F SPINK5 | 5.80e-11 | 242 | 59 | 11 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D WDR90 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 4.98e-09 | 281 | 59 | 10 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D WDR90 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 4.98e-09 | 281 | 59 | 10 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.32e-07 | 320 | 59 | 9 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D CD248 CDC42EP2 F2 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.58e-05 | 1049 | 59 | 12 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | ASXL1 TBC1D3 TBC1D3H TBC1D3L EGF TBC1D3D BARHL1 GAS1 TBC1D3G TBC1D3C TBC1D3B ENKD1 TBC1D3K TBC1D3F | 3.67e-05 | 1466 | 59 | 14 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | ASXL1 TBC1D3 TBC1D3H TBC1D3L EGF TBC1D3D ZSWIM5 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.48e-05 | 1153 | 59 | 12 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D BARHL1 GAS1 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.59e-04 | 1075 | 59 | 11 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000 | ASXL1 TBC1D3 TBC1D3H FMN1 BARHL1 GAS1 NEURL1 TBC1D3C TBC1D3B TBC1D3F | 3.52e-04 | 986 | 59 | 10 | PCBC_ratio_ECTO_vs_SC_1000 |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 166 | 60 | 4 | a2ce44702a0cd5fa5872cac3302d3c451205feef | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 166 | 60 | 4 | 0f641302a6b71c4badaaf20f51162bfc2386b167 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Platelet|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.04e-04 | 181 | 60 | 4 | 724efbc200e8388829bc7d81830c2689a95fa838 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.06e-04 | 182 | 60 | 4 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 183 | 60 | 4 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 183 | 60 | 4 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 183 | 60 | 4 | 269afec240a756eec3bbae5f30ec784281af3433 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 184 | 60 | 4 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.13e-04 | 185 | 60 | 4 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-04 | 185 | 60 | 4 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 188 | 60 | 4 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 192 | 60 | 4 | 859a32c9e4ed6961897b2ccaecde73a599471df9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 192 | 60 | 4 | 89e1da82fa2069dac7adb9cba3e8b6c0179e0dc5 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 193 | 60 | 4 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-04 | 194 | 60 | 4 | ca1f24070424b44b7a442e4fca761ebfbe24b063 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 194 | 60 | 4 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 195 | 60 | 4 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.41e-04 | 196 | 60 | 4 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-04 | 197 | 60 | 4 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.46e-04 | 198 | 60 | 4 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.46e-04 | 198 | 60 | 4 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.46e-04 | 198 | 60 | 4 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.46e-04 | 198 | 60 | 4 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-04 | 199 | 60 | 4 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-04 | 199 | 60 | 4 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-04 | 199 | 60 | 4 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-04 | 199 | 60 | 4 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | distal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.49e-04 | 199 | 60 | 4 | 547a7c30abc730af2670aee00c7a6af60426c9ac | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 200 | 60 | 4 | 17ffdbc13332bd3ed1d54abcd7af20267dd4b234 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.52e-04 | 200 | 60 | 4 | ef222dc4a205d670172dae74990bdb952ac92e5b | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-04 | 200 | 60 | 4 | a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.52e-04 | 200 | 60 | 4 | 98a994692440cb4f505b050276f0c8022c814a21 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 200 | 60 | 4 | 5c6520dc4c4693827f6680651785680b5883afb8 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-04 | 200 | 60 | 4 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 200 | 60 | 4 | 665df8391d2ebcfc6536318612f4992852b5e2b8 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-04 | 200 | 60 | 4 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-04 | 200 | 60 | 4 | 10f0c20ba7c71d9e2e177597f85b41cb40f0d878 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-04 | 200 | 60 | 4 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| Drug | AZFd | 2.42e-07 | 23 | 54 | 4 | CID000196489 | |
| Drug | PKI166 | 5.09e-06 | 48 | 54 | 4 | CID006918403 | |
| Drug | hydantoin-5-propionic acid | 1.63e-05 | 21 | 54 | 3 | CID000000782 | |
| Drug | 4',5'-dimethylfluorescein | 1.65e-05 | 3 | 54 | 2 | CID003082937 | |
| Disease | polychlorinated biphenyls measurement, gestational serum measurement | 1.91e-04 | 12 | 51 | 2 | EFO_0007042, EFO_0007964 | |
| Disease | glomerulonephritis (is_marker_for) | 4.92e-04 | 19 | 51 | 2 | DOID:2921 (is_marker_for) | |
| Disease | CCL4 measurement | 5.46e-04 | 20 | 51 | 2 | EFO_0004751 | |
| Disease | lymphocyte:monocyte ratio | 1.55e-03 | 288 | 51 | 4 | EFO_0600088 | |
| Disease | macrophage inflammatory protein 1b measurement | 1.70e-03 | 136 | 51 | 3 | EFO_0008219 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DRALDTTAPRGPCIG | 46 | Q9H0I2 | |
| DPCRFALTSRGPEGG | 426 | Q86VW2 | |
| CTRPVDVRDSGGRPL | 231 | Q96PG8 | |
| CRELGGDLATPRTPE | 51 | Q9HCU0 | |
| RDCLETGTPRPGGAS | 56 | Q9BZE3 | |
| CTGRSADLLLPPGDT | 866 | Q92625 | |
| LSPGEILGCTSPRLS | 211 | Q9BZG8 | |
| PLLPDSCETGTGLAR | 1176 | Q8IXJ9 | |
| SRGGTRELLPCGPET | 736 | Q76L83 | |
| PTLDLPCSIGRTEGT | 431 | Q9Y483 | |
| GRVLPDPREACGSSS | 461 | P0DJD3 | |
| GRVLPDPREACGSSS | 461 | P0DJD4 | |
| GRVLPDPREACGSSS | 461 | P0C7P1 | |
| GRVLPDPREACGSSS | 461 | A6NEQ0 | |
| DIRVPSSDGLSGPCR | 81 | Q9Y3T6 | |
| CSSTEAGGDGIRRPP | 271 | Q68DA7 | |
| TCPGDRSAITPGGLR | 411 | P34897 | |
| LLVCPGEGLSEPRSR | 181 | Q5SQ64 | |
| LICTRESDPVRGPDG | 786 | Q9NQ38 | |
| ELTGTCSLLGPDLRP | 121 | P38570 | |
| STNCPRPERGGLETS | 56 | Q9UMF0 | |
| GPGPDLESLISRVCR | 261 | Q6ZNW5 | |
| RAIEPCLPRTSGGGA | 141 | P54826 | |
| LCVVDLSRGSTPLGP | 366 | Q0VG06 | |
| LDCGRPEPSARIVGG | 36 | Q5K4E3 | |
| TRTATVCGRELPDGP | 86 | O14613 | |
| SCGPRTRREPSSGEE | 6 | Q14241 | |
| AGRLSEPGLICPDST | 941 | P01133 | |
| PGDPRLVISSGCATR | 436 | O43909 | |
| LRPGDESTPRGRCDS | 691 | Q6ZU35 | |
| GVVSGGAEPCSRPRR | 216 | Q9UKQ9 | |
| REPRLVGGDIPCSGR | 476 | Q86VB7 | |
| CEPRGGEPSSGPVRR | 351 | O75462 | |
| PCGELLERPGTRSLA | 236 | P59044 | |
| GGTRRASPPEFCVLG | 1246 | A6NGG8 | |
| RTLPPIEGTLGLSAC | 426 | Q92834 | |
| RVPPTTEGTRGLLSC | 506 | Q6ZW31 | |
| VAVLGEPGSDRRSCP | 1401 | O14513 | |
| RGDTFCPGPTLSEDR | 921 | P98174 | |
| PERPRTAGRTCEGTE | 826 | Q13796 | |
| SCVSSGRPDRVPGGI | 781 | O75592 | |
| RSSTPCPGGAVREDT | 411 | B9A6J9 | |
| DCRSPGLLDTTPIRG | 1466 | Q8IY92 | |
| PAREDCRGLTGPLQS | 651 | Q09428 | |
| TDSDGRFRIPGLCPD | 256 | O75339 | |
| RSSTPCPGGAVREDT | 411 | A6NDS4 | |
| RSSTPCPGGAVREDT | 411 | P0C7X1 | |
| GPVRSAPCRTGTLEG | 6 | Q7M4L6 | |
| RTGSCEGFLPDPVLR | 346 | Q96KV7 | |
| CTVTAPGLAGIPGRR | 1081 | Q9P217 | |
| GVTTCDPGTLRPADL | 356 | O76050 | |
| RSSTPCPGGAVREDT | 411 | A6NER0 | |
| EEFPGGLTIRCSPGR | 1146 | Q8IZH2 | |
| RSSTPCPGGAVREDT | 411 | A0A087X179 | |
| PRVTCPSTGLGLGRT | 2366 | Q96JG9 | |
| PRTFGSGEADCGLRP | 326 | P00734 | |
| RSSTPCPGGAVREDT | 411 | A0A087WVF3 | |
| RSSTPCPGGAVREDT | 411 | Q6DHY5 | |
| RSSTPCPGGAVREDT | 411 | Q8IZP1 | |
| RSSTPCPGGAVREDT | 411 | A0A087X1G2 | |
| RSSTPCPGGAVREDT | 411 | A0A087WXS9 | |
| RSSTPCPGGAVREDT | 411 | Q6IPX1 |